Who
Anthony Mancini
Officer
Company insider
Files Form 4 as: Officer, Revolution Medicines.
In numbers
- Trades disclosed
- 64
- Buys
- 0
- Sells
- 9
- Bought
- $0
- Sold
- $19.6M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 25 Mar 2026
- Last trade
- 25 Sep 2026
- Last filed
- 28 Sep 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Sep 2026filed 28 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Code M | $105K3,121 at $33.62 | filing |
| 25 Sep 2026filed 28 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $626K3,121 at $200.54 | filing |
| 25 Sep 2026filed 28 Sep 2026 | RVMD Revolution Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,121 at $0.00 | filing |
| 25 Sep 2026filed 28 Sep 2026 | RVMD Revolution Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,121 at $0.00 | filing |
| 25 Sep 2026filed 28 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Code M | $105K3,121 at $33.62 | filing |
| 25 Sep 2026filed 28 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $626K3,121 at $200.54 | filing |
| 24 Sep 2026filed 28 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $117K587 at $200.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $117K587 at $200.00 | filing |
| 18 Sep 2026filed 22 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $347K1,764 at $196.94 | filing |
| 18 Sep 2026filed 22 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $347K1,764 at $196.94 | filing |
| 16 Sep 2026filed 18 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $5,26627 at $195.05 | filing |
| 16 Sep 2026filed 18 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $348K1,747 at $199.30 | filing |
| 16 Sep 2026filed 18 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $5,26627 at $195.05 | filing |
| 16 Sep 2026filed 18 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $348K1,747 at $199.30 | filing |
| 10 Sep 2026filed 14 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Code M | $315K9,363 at $33.62 | filing |
| 10 Sep 2026filed 14 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $1.2M6,019 at $203.28 | filing |
| 10 Sep 2026filed 14 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $1.1M5,530 at $204.14 | filing |
| 10 Sep 2026filed 14 Sep 2026 | RVMD Revolution Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —9,363 at $0.00 | filing |
| 10 Sep 2026filed 14 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $496K2,420 at $205.05 | filing |
| 10 Sep 2026filed 14 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $243K1,179 at $206.10 | filing |
News
Revolution Medicines' Pancreatic Cancer Drug Gets Positive EU ReviewRVMD · finanzen.ch · 15 Oct 2026Revolution Medicines (NASDAQ:RVMD) Shares Up 3.4% on Analyst UpgradeRVMD · themarketsdaily.com · 14 Oct 2026Propanc Biopharma Reports Data Showing 90% Tumor Growth Inhibition with PRP in Pancreatic Cancer Models, Contrasting Profile with Revolution Medicines' DaraxonrasibRVMD · manilatimes.net · 7 Oct 2026
0 headlines in the last 90 days name Anthony Mancini; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.